Sevoflurane mimics ischemic preconditioning effects on coronary flow and nitric oxide release in isolated hearts

Anesthesiology

Volumn 91, Issue 3, 1999, Pages 701-712

  Novalija, Enis ^b   Fujita, Satoshi ^a   Kampine, John P ^b   Stowe, David F ^b,c  

^a SAPPORO MEDICAL UNIVERSITY   (Japan)

^b CLEMENT J ZABLOCKI VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c MEDICAL COLLEGE OF WISCONSIN   (United States)

Author keywords

Anesthetics; Bradykinin; Cardiac injury; Coronary vasculature; Myocardial ischemia; Nitroprusside

Indexed keywords

GLIBENCLAMIDE; NITRIC OXIDE; NITROPRUSSIDE SODIUM; POTASSIUM CHANNEL; SEVOFLURANE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; GUINEA PIG; HEART MUSCLE CONTRACTILITY; HEART MUSCLE ISCHEMIA; HEART PROTECTION; INHALATION ANESTHESIA; ISOLATED HEART; NONHUMAN; PRIORITY JOURNAL; REPERFUSION INJURY;

ANESTHETICS, INHALATION; ANIMALS; CORONARY CIRCULATION; GUINEA PIGS; HEART; HEMODYNAMIC PROCESSES; ISCHEMIC PRECONDITIONING; METHYL ETHERS; NITRIC OXIDE; POTASSIUM CHANNELS; SUPEROXIDES;

EID: 0032871394     PISSN: 00033022     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000542-199909000-00023     Document Type: Article

References (51)

1. Murry CE, Jennings RB, Reimer KA: Preconditioning with ischemia: A delay of lethal cell injury in ischemic myocardium. Circulation 1986; 74:1124-36
2. Cribier A, Korsatz L, Koning R, Rath P, Gamra H, Stix G, Merchant S, Chan C, Letac B: Improved myocardial ischemic response and enhanced collateral circulation with long repetitive coronary occlusion during angioplasty: A prospective study. J Am Coll Cardiol 1992; 20:578-86
3. Reimer KA. Murray CE, Yamasawa I, Hill ML, Jennings RB: Four brief periods of myocardial ischemia cause no cumulative ATP loss or necrosis. Am J Physiol 1986; 251:H1306-15
4. Cohen MV, Liu GS, Downey JM: Preconditioning causes improved wall motion as well as smaller infarcts after transient coronary occlusion in rabbits. Circulation 1991; 84:341-9
5. Schott RJ, Rohmann S, Braun ER, Schaper W: Ischemic preconditioning reduces infarct size in swine myocardium. Circ Res 1990; 66:1133-42
6. Li YW, Whittaker P, Kloner RA: The transient nature of the effect of ischemic preconditioning on myocardial infarct size and ventricular arrhythmia. Am Heart J 1992; 123:346-53
7. Kersten JR, Orth KG, Pagel PS, Mei DA, Gross GJ, Warltier DC: Role of adenosine in isoflurane-induced cardioprotection. ANESTHESIOLOGY 1997; 86:1128-39
8. Richard V, Kaeffer N, Tron C, Thuillez C: Ischemic preconditioning protects against coronary endothelial dysfunction induced by ischemia and reperfusion. Circulation 1994; 89:1254-61
9. DeFily DV, Chilian WM: Preconditioning protects coronary arteriolar endothelium from ischemia-reperfusion injury. Am J Physiol 1993; 265:H700-6
10. Giannella E, Mochmann H-C, Levi R: Ischemic preconditioning prevents the impairment of hypoxic coronary vasodilatation caused by ischemia/reperfusion. Circ Res 1997; 81:415-22
11. Bauer B, Simkhovich BZ, Kloner RA, Przyklenk K: Does preconditioning protect the coronary vasculature from subsequent ischemia/reperfusion inury? Circulation 1993; 88:659-72
12. Marijic J, Stowe DF, Turner LA, Kampine JP, Bosnjak ZJ: Differential protective effects of halothane and isoflurane against hypoxic and reoxygenation injury in the isolated guinea pig heart. ANESTHESIOLOGY 1990; 73:976-83
13. Buljubasic N, Marijic J, Stowe DF, Kampine JP, Bosnjak ZJ: Halothane reduces dysrhythmias and improves contractile function after global hypoperfusion in isolated hearts. Anesth Analg 1992; 74: 384-94
14. Buljubasic N, Stowe DF, Marijic J, Roerig DL, Kampine JP, Bosnjak ZJ: Halothane reduces release of adenosine, inosine, and lactate with ischemia and reperfusion in isolated hearts. Anesth Analg 1993; 76:54-62
15. Stowe DF, Habazettl H, Graf BM, Kampine JP, Bosnjak ZJ: One-day hypothermie preservation of isolated hearts with halothane improves cardiac function better than low calcium. ANESTHESIOLOGY 1995; 83:1065-77
16. ATP channel activation. ANESTHESIOLOGY 1998; 88:233-44
17. National Institutes of Health: Guide for the Care and Use of Laboratory Animals, NIH publication #95-23. Bethesda, MD, 1995.
18. Fujita S, Roerig DL, Chung WW, Bosnjak ZJ, Stowe DF: Volatile anesthetics do not alter bradykinin-induced release of nitric oxide or L-citrulline in crystalloid perfused guinea pig hearts. ANESTHESIOLOGY 1998; 89:421-33
19. Fujita S, Roerig DL, Bosnjak ZJ, Stowe DF: Effects of vasodilators and perfusion pressure on coronary flow and simultaneous release of nitric oxide from guinea pig isolated hearts. Cardiovasc Res 1998; 38:655-67
20. Tsukahara H, Gordienko DV, Goligorsky MS: Continuous monitoring of nitric oxide release from human umbilical vein endothelial cells. Biochem Biophys Res Commun 1993; 193:722-9
21. Fralix TA, Steenbergen C, London RE, Murphy E: Glibenclamide does not abolish the protective effect of preconditioning on stunning in the isolated perfused rat heart. Cardiovasc Res 1993; 27:630-7
22. Grover GJ, Dzwonczyk S, Sleph PG, Sargent CA: The ATP-sensitive potassium channel blocker glibenclamide (glyburide) does not abolish preconditioning in isolated ischemic rat hearts. J Pharmacol Exp Ther 1993; 265:559-64
23. 1 adenosine receptors in rabbit heart. Circulation 1991; 84:350-6
24. Schultz JE, Hsu AK, Gross GJ: Morphine mimics the cardioprotective effect of ischemic preconditioning via a glibenclamide-sensitive mechanism in the rat heart. Circ Res 1996; 78:1100-4
25. Baines CP, Wang L, Cohen MV, Downey JM: Protein tyrosine kinase is downstream of protein kinase C for ischemic preconditioning's anti-infarct effect in the rabbit heart. J Mol Cell Cardiol 1998; 30:383-92
26. Speechly-Dick ME, Grover GJ, Yellon DM: Does ischemic preconditioning in the human involve protein kinase C and the ATP-dependent K+ channel? Studies of contractile function after simulated ischemia in an atrial in vitro model. Circ Res 1995; 77:1030-5
27. Speechly-Dick ME, Mocanu MM, Yellon DM: Protein kinase C: Its role in ischemic preconditioning in the rat. Circ Res 1994; 75:586-90
28. Weinbrenner C, Liu G-S, Cohen MV, Downey JM: Phosphorylation of tyrosine 182 of p38 mitogen-activated protein kinase correlates with the protection of preconditioning in the rabbit heart. J Mol Cell Cardiol 1997; 29:2383-91
29. Gross GJ, Auchampach JA: Blockade of ATP-sensitive potassium channels prevents myocardial preconditioning in dogs. Circ Res 1992; 70:223-33
30. Mizumura T, Nithipatikom K, Gross GJ: Bimakalim, an ATP-sensitive potassium channel opener, mimics the effects of ischemic preconditioning to reduce infarct size, adenosine release, and neutrophil function in dogs. Circulation 1995; 92:1236-45
31. Vegh A, Szekeres L, Parratt J: Preconditioning of the ischaemic myocardium: Involvement of the L-arginine nitric oxide pathway. Br J Pharmacol 1992; 107:648-52
32. Schultz JJ, Zhenhai Y, Cavero I, Gross GJ: Glibenclamide-induced blockade of ischemic preconditioning is time dependent in intact rat heart. Am J Physiol 1997; 272(Heart Circ Physiol 41): H2607-15
33. Bilinska M, Maczewski M, Bcresewicz A: Donors of nitric oxide mimic effects of ischaemic preconditioning on reperfusion induced arrhythmias in isolated rat heart. Mol Cell Biochem 1996; 160/161: 265-71
34. Weselcouch EO, Baird AJ, Sleph P, Grover GJ: Inhibition of nitric oxide synthesis does not affect ischemic preconditioning in isolated perfused rat hearts. Am J Physiol 1995; 268:H242-9
35. Lu HR, Remeysen P, De Clerek F: Does the antiarrhythmic effect of ischemic preconditioning in rats involve the L-arginine nitric oxide pathway? J Cardiovasc Pharmacol 1995; 25:524-30
36. Wall TM, Sheeny R, Hartman JC: Role of bradykinin in myocardial preconditioning. J Pharmacol Exp Ther 1994; 270:681-9
37. Goto M, Liu Y, Yang XM, Ardell JL, Cohen MV, Downey JM: Role of bradykinin in protection of ischemic preconditioning in rabbit hearts. Circ Res 1995; 77:611-21
38. Baines CP, Goto M, Downey JM: Oxygen radicals released during ischemic preconditioning contribute to cardioprotection in the rabbit myocardium. J Mol Cell Cardiol 1997; 29:207-16
39. Bolli R: The early and late phases of preconditioning against myocardial stunning and the essential role of oxyradicals in the late phase: An overview. Basic Res Cardiol 1996; 91:57-63
40. Beckman JS, Wink DA, Crow JP: Nitric oxide and peroxynitrate, Methods in Nitric Oxide Research. Edited by Feelisch M, Stamler JS. New York, John Wiley & Sons, 1996, pp 61-70
41. Bolli R. Manchikalapudi S, Tang X-L, Takano H, Qiu Y, Guo Y, Zhang Q, Jadoon AK: The protective effect of late preconditioning against myocardial stunning in conscious rabbits is mediated by nitric oxide synthase. Circ Res 1997; 81:1094-107
42. Shinbo A, Iijima T: Potentiation by nitric oxide of the ATP-sensitive K+ current induced by K+ channel openers in guinea-pig ventricular cells. British Journal of Pharmacology 1997; 120:1568-74
43. ATP channel antagonist, attenuates the cardioprotective effects of isoflurane in stunned myocardium. Anesth Analg 1996; 83:27-33
44. Cason BA, Gamperi AK, Slocum RE, Hickey RF: Anesthetic-induced preconditioning. ANESTHESIOLOGY 1997; 87:1182-90
45. Hart JL, Bina S, Freas W, Van Dyke RA, Muldoon SM: Effects of halothane on EDRF/cGMP-mediated vascular smooth muscle relaxations. ANESTHESIOLOGY 1993; 79:323-31
46. Brendel JK, Johns RA: Isoflurane does not vasodilate rat thoracic aortic rings by endothelium-derived relaxing factor or other cyclic GMP-mediated mechanisms. ANESTHESIOLOGY 1992; 77: 126-31
47. Crystal GJ, Kim SJ, Salem MR, Khoury E, Gurevicius J: Nitric oxide does not mediate coronary vasodilation by isoflurane. ANESTHESIOLOGY 1994; 81:209-20
48. Stowe DF, Ebert TE: Neural and endothelial control of the peripheral circulation:implications for anesthesia: Part II. Endothelium mediated effects in the normal and diseased circulation. J Cardiovasc Anesthesiol 1996; 10:159-71
49. ATP channels, and ischemic preconditioning in dogs. Am J Physiol 1993; 264: H1327-36
50. Stowe DF, Varadarajan S, Heisner JS, An JZ: Coronary vasodilators moderately precondition isolated hearts against ischemia reperfusion injury. FASEB J 1999; 13:A763
51. 2+ Loading and improves contractility in intact hearts. ANESTHESIOLOGY 1998; 89:A631